117 related articles for article (PubMed ID: 38493369)
1. Genome-Wide Association Study of Atorvastatin Pharmacokinetics: Associations With SLCO1B1, UGT1A3, and LPP.
Mykkänen AJH; Tarkiainen EK; Taskinen S; Neuvonen M; Paile-Hyvärinen M; Lilius TO; Tapaninen T; Klein K; Schwab M; Backman JT; Tornio A; Niemi M
Clin Pharmacol Ther; 2024 Jun; 115(6):1428-1440. PubMed ID: 38493369
[TBL] [Abstract][Full Text] [Related]
2. A Genome-wide Association Study of Circulating Levels of Atorvastatin and Its Major Metabolites.
Turner RM; Fontana V; Zhang JE; Carr D; Yin P; FitzGerald R; Morris AP; Pirmohamed M
Clin Pharmacol Ther; 2020 Aug; 108(2):287-297. PubMed ID: 32128760
[TBL] [Abstract][Full Text] [Related]
3. Effects of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of atorvastatin and 2-hydroxyatorvastatin in healthy Korean subjects.
Lee YJ; Lee MG; Lim LA; Jang SB; Chung JY
Int J Clin Pharmacol Ther; 2010 Jan; 48(1):36-45. PubMed ID: 20040338
[TBL] [Abstract][Full Text] [Related]
4. The effect of
Wang Y; Tian Y; Lv P; Chen L; Luo W; Jing X; Li H; Tan Z; Wang Y; Zhou H; Ouyang DS
Pharmazie; 2017 Jun; 72(6):365-368. PubMed ID: 29442027
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Pharmacogenomic Study Reveals an Important Role of UGT1A3 in Montelukast Pharmacokinetics.
Hirvensalo P; Tornio A; Neuvonen M; Tapaninen T; Paile-Hyvärinen M; Kärjä V; Männistö VT; Pihlajamäki J; Backman JT; Niemi M
Clin Pharmacol Ther; 2018 Jul; 104(1):158-168. PubMed ID: 28940478
[TBL] [Abstract][Full Text] [Related]
6. UGT1A3 and Sex Are Major Determinants of Telmisartan Pharmacokinetics-A Comprehensive Pharmacogenomic Study.
Hirvensalo P; Tornio A; Launiainen T; Paile-Hyvärinen M; Tapaninen T; Neuvonen M; Backman JT; Niemi M
Clin Pharmacol Ther; 2020 Oct; 108(4):885-895. PubMed ID: 32498119
[TBL] [Abstract][Full Text] [Related]
7. Effects of single nucleotide polymorphisms and haplotypes of the SLCO1B1 gene on the pharmacokinetic profile of atorvastatin in healthy Macedonian volunteers.
Daka A; Dimovski A; Kapedanovska A; Vavlukis M; Eftimov A; Labachevski N; Jakjovski K; Geshkovska MN; Nebija D; Mladenovska K
Pharmazie; 2015 Jul; 70(7):480-8. PubMed ID: 26373210
[TBL] [Abstract][Full Text] [Related]
8. Effect of polymorphisms in CYP3A4, PPARA, NR1I2, NFKB1, ABCG2 and SLCO1B1 on the pharmacokinetics of lovastatin in healthy Chinese volunteers.
Zhao G; Liu M; Wu X; Li G; Qiu F; Gu J; Zhao L
Pharmacogenomics; 2017 Jan; 18(1):65-75. PubMed ID: 27967318
[TBL] [Abstract][Full Text] [Related]
9. Genomewide Association Study of Simvastatin Pharmacokinetics.
Mykkänen AJH; Taskinen S; Neuvonen M; Paile-Hyvärinen M; Tarkiainen EK; Lilius T; Tapaninen T; Backman JT; Tornio A; Niemi M
Clin Pharmacol Ther; 2022 Sep; 112(3):676-686. PubMed ID: 35652242
[TBL] [Abstract][Full Text] [Related]
10. CYP2C9*3(1075A > C), ABCB1 and SLCO1B1 genetic polymorphisms and gender are determinants of inter-subject variability in pitavastatin pharmacokinetics.
Zhou Q; Chen QX; Ruan ZR; Yuan H; Xu HM; Zeng S
Pharmazie; 2013 Mar; 68(3):187-94. PubMed ID: 23556337
[TBL] [Abstract][Full Text] [Related]
11. UHPLC-MS/MS method for determination of atorvastatin calcium in human plasma: Application to a pharmacokinetic study based on healthy volunteers with specific genotype.
Xia B; Li Y; Zhang Y; Xue M; Li X; Xu P; Xia T; Chen S
J Pharm Biomed Anal; 2018 Oct; 160():428-435. PubMed ID: 30130726
[TBL] [Abstract][Full Text] [Related]
12. Effects of two functionally important SLCO1B1 gene polymorphisms on pharmacokinetics of atorvastatin.
Rajput TA; Naveed AK; Farooqi ZR; Khan S
Pak J Pharm Sci; 2017 Jul; 30(4):1363-1370. PubMed ID: 29039339
[TBL] [Abstract][Full Text] [Related]
13. Association of SLCO1B1 c.521T>C (rs4149056) with discontinuation of atorvastatin due to statin-associated muscle symptoms.
Linskey DW; English JD; Perry DA; Ochs-Balcom HM; Ma C; Isackson PJ; Vladutiu GD; Luzum JA
Pharmacogenet Genomics; 2020 Dec; 30(9):208-211. PubMed ID: 32453264
[TBL] [Abstract][Full Text] [Related]
14. Almorexant effects on CYP3A4 activity studied by its simultaneous and time-separated administration with simvastatin and atorvastatin.
Hoch M; Hoever P; Theodor R; Dingemanse J
Eur J Clin Pharmacol; 2013 Jun; 69(6):1235-45. PubMed ID: 23334403
[TBL] [Abstract][Full Text] [Related]
15. Lack of association between SLCO1B1 polymorphism and the lipid-lowering effects of atorvastatin and simvastatin in Chinese individuals.
Fu Q; Li YP; Gao Y; Yang SH; Lu PQ; Jia M; Zhang LR
Eur J Clin Pharmacol; 2013 Jun; 69(6):1269-74. PubMed ID: 23263738
[TBL] [Abstract][Full Text] [Related]
16. The effect of CYP3A4*1G allele on the pharmacokinetics of atorvastatin in Chinese Han patients with coronary heart disease.
He BX; Shi L; Qiu J; Zeng XH; Zhao SJ
J Clin Pharmacol; 2014 Apr; 54(4):462-7. PubMed ID: 24214373
[TBL] [Abstract][Full Text] [Related]
17. Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?
Birmingham BK; Bujac SR; Elsby R; Azumaya CT; Wei C; Chen Y; Mosqueda-Garcia R; Ambrose HJ
Eur J Clin Pharmacol; 2015 Mar; 71(3):341-55. PubMed ID: 25673568
[TBL] [Abstract][Full Text] [Related]
18. The influences of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of simvastatin, in relation to CYP3A4 inhibition.
Jiang F; Choi JY; Lee JH; Ryu S; Park ZW; Lee JG; Na HS; Lee SY; Oh WY; Chung MW; Choi SE
Pharmacogenomics; 2017 Apr; 18(5):459-469. PubMed ID: 28350522
[TBL] [Abstract][Full Text] [Related]
19. No Effect of SLCO1B1 and CYP3A4/5 Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Ticagrelor in Healthy Chinese Male Subjects.
Li M; Hu Y; Li H; Wen Z; Hu X; Zhang D; Zhang Y; Xiao J; Tang J; Chen X
Biol Pharm Bull; 2017; 40(1):88-96. PubMed ID: 28049954
[TBL] [Abstract][Full Text] [Related]
20. The atorvastatin metabolic phenotype shift is influenced by interaction of drug-transporter polymorphisms in Mexican population: results of a randomized trial.
León-Cachón RBR; Bamford AD; Meester I; Barrera-Saldaña HA; Gómez-Silva M; Bustos MFG
Sci Rep; 2020 Jun; 10(1):8900. PubMed ID: 32483134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
